Uday Popat
M.D. Anderson Cancer Center · Department of Blood and Marrow Transplantation, University of Texas, M.D. Anderson Cancer Center · Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Uday Popat as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:47 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06973668 · A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host DiseaseM.D. Anderson Cancer Center · recruiting · AML · principal investigator
- Ph2NCT06345495 · High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With SplenomegalyM.D. Anderson Cancer Center · recruiting · Splenomegaly, Myelofibrosis · principal investigator
- Ph2NCT02410551 · Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)M.D. Anderson Cancer Center · terminated · Myeloproliferative Diseases · principal investigator
- Ph2NCT01927731 · Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing TransplantM.D. Anderson Cancer Center · completed · Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient · principal investigator
- Ph2NCT01572662 · Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine ConditioningM.D. Anderson Cancer Center · completed · Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia · principal investigator
- Ph2NCT01000051 · Eltrombopag for Post Transplant ThrombocytopeniaM.D. Anderson Cancer Center · completed · Thrombocytopenia · study chair
- Ph2NCT00475020 · Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic SyndromeM.D. Anderson Cancer Center · completed · Myelofibrosis · principal investigator
- Ph2NCT00288626 · High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) StudyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Relapsing-Remitting Multiple Sclerosis · study chair
- N/ANCT00073879 · Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationBaylor College of Medicine · completed · Kidney Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:47 UTC. The ranking covers the 200 most relevant of 89 PubMed records, and a shared surname and initials can bring in a namesake. All 89 on PubMed
- 460 citationsRCR 53.4
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.J Clin Invest · 2016412 citationsRCR 12.0
- Cord-blood engraftment with ex vivo mesenchymal-cell coculture.N Engl J Med · 2012371 citationsRCR 10.3
- 277 citationsRCR 5.2
- Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.Biol Blood Marrow Transplant · 2012203 citationsRCR 6.1
- A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients.Blood Adv · 2020194 citationsRCR 8.9
- Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.Biol Blood Marrow Transplant · 2014183 citationsRCR 6.1
- 132 citationsRCR 4.6
- 125 citationsRCR 4.6
- Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia.J Clin Oncol · 2022116 citationsRCR 7.6